In contrast to the systemic administration of the IFNs (Figure 1D and 1E), local administration was found to be highly effective in mice after partial tumor removal, using two doses of the IFN combination, a lower dose (10 ng) and a higher dose (50 ng) (Figure 1D and 1E). This evidence concerns the gene IFNA1 and neoplasm.